Register
Page 17 of 17 FirstFirst ... 7151617
Results 161 to 169 of 169
  1. #161
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475
    Quote Originally Posted by Triển View Post
    Theo bản tin dưới đây của VOA thì thấy tội nghiệp bà ca sĩ này ghê. 77 tuổi sống một mình phải tự lo mọi thứ mà không dựa dẫm vào con cái đến cả việc nhập viện. Tui cũng chúc bà tai qua nạn khỏi bước vào năm mới.




    Ca sỹ Lệ Thu nhiễm Covid, gia đình ‘cầu nguyện và hy vọng’


    Phía ngoài Orange Coast Medical Center nơi ca sỹ Lệ Thu đang được chữa trị vì Covid-19





    Thành thật chia buồn với tang quyến của bà
    và những người hâm mộ bà ca sĩ Lệ Thu







    Danh ca Lệ Thu qua đời sau thời gian chống chọi với Covid-19
    January 16, 2021

    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

  2. #162
    Biệt Thự
    Join Date
    Sep 2011
    Posts
    4,603
    Xin chia buồn . Cô đơn đến lúc chết .

  3. #163
    Biệt Thự
    Join Date
    Sep 2011
    Posts
    1,627
    Rest in Peace.
    Có khi trời nắng, có khi trời mưa.

  4. #164
    Biệt Thự
    Join Date
    Sep 2011
    Posts
    1,627
    What to Know About Vaccine-Related Deaths, Allergies

    By John Lauerman
    and Jason Gale
    January 18, 2021, 4:33 AM EST Updated on January 18, 2021, 9:02 AM EST

    (NU tạm dịch nhanh phần đầu, bấm link để đọc thêm)


    Những Điều Cần Biết Về Những Cái Chết, Dị Ứng Liên Quan Đến Covid-19 Vaccine


    Như tất cả các loại thuốc mới, những vắc xin đã được phê duyệt để bảo vệ từ Covid-19 đi kèm với một số lo ngại về an toàn và tác dụng phụ. Trong số những người đã tiêm chủng hai liều vắc-xin của các hãng phương Tây , một từ Pfizer Inc. và BioNTech SE, và một từ Moderna Inc., nhiều người đã bị sốt, nhức đầu và đau tại chỗ tiêm. Những tác dụng phụ này thường nhanh chóng biến đi. Đáng lo ngại hơn, Na Uy đã báo cáo trường hợp tử vong ở những người cao tuổi có tình trạng sức khỏe bệnh lý nền nghiêm trọng sau khi tiêm vắc-xin Pfizer-BioNTech - có thể liên quan đến những tác dụng phụ đó. Một số người khác nhận được các mũi tiêm khác nhau đã có một phản ứng dị ứng nghiêm trọng, nhưng có thể điều trị được, gọi là sốc phản vệ



    1. Những gì được biết về những cái chết?

    Ba mươi ba cái chết đã được báo cáo vào giữa tháng Giêng trong số khoảng 42.000 người được tiêm vắc-xin Pfizer-BioNTech ở Na Uy, nơi mà các nhà chức trách đã ưu tiên tiêm chủng cho các cư dân trong viện dưỡng lão. Những người chết đều ở độ tuổi “75 trở lên” (tuổi chính xác không được đưa ra vì lý do riêng tư) và bao gồm cả những bệnh nhân mắc bệnh nan y được dự đoán chỉ còn sống được vài tuần hoặc vài tháng. Tất cả các trường hợp tử vong xảy ra trong vài ngày sau khi tiêm chủng đều được nghiên cứu cẩn thận . Các cơ quan y tế ở Na Uy cho biết không có bằng chứng về mối liên hệ trực tiếp giữa 33 trường hợp và vắc xin mà họ đã tiếp nhận. Trung bình 400 người chết mỗi tuần trong các viện dưỡng lão và các cơ sở chăm sóc dài hạn, theo Cơ quan Thuốc Na Uy. Sigurd Hortemo, bác sĩ chính của cơ quan, cho biết ông không thể loại trừ rằng các phản ứng ngược phổ biến đối với vắc-xin, chẳng hạn như sốt và buồn nôn, có thể đe dọa tính mạng ở những bệnh nhân có vấn đề bệnh lý nền nghiêm trọng.


    2. Đã có người chết ở những nơi khác?

    Tại Đức, nơi hơn 800.000 người đã tiêm hai liều vắc-xin Pfizer-BioNTech đầu tiên. Viện Paul Ehrlich đã điều tra ít nhất bảy trường hợp người cao tuổi tử vong ngay sau khi tiêm chủng. Trong báo cáo của mình, họ cho biết các ca tử vong có thể là do các bệnh nền của bệnh nhân bao gồm ung thư biểu mô, suy thận và bệnh Alzheimer, không phải do tiệm chủng.


    3. Những phản ứng nào đã xảy ra những trường hợp tử vong này?

    Các ca tử vong ở Na Uy có liên quan đến sốt, buồn nôn và tiêu chảy - những phản ứng tương đối phổ biến, chỉ tồn tại trong thời gian ngắn mà một số người có thể gặp phải sau hầu hết mọi trường hợp tiêm chủng, theo thông tin từ Cơ quan điều trị của Australia. ..


    xem tiếp: https://www.bloomberg.com/news/artic...gies-quicktake
    Có khi trời nắng, có khi trời mưa.

  5. #165
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475




    AstraZeneca's COVID-19 shot shouldn't be given to people over 65, Germany's vaccine committee reportedly says


    A nurse administers a Covid-19 vaccine to an elderly, as Jordan starts the national vaccination campaign at a special vaccination clinic on January 13, 2021 in Amman, Jordan. Photo by Jordan Pix/Getty Images

    The COVID-19 vaccine developed by AstraZeneca and the University of Oxford shouldn't be given to people over age 65, Germany's main public health agency recommended on Thursday, multiple media outlets reported.

    "There are currently insufficient data available to assess the vaccine efficacy from 65 years of age," said the Vaccine Commission at the Robert Koch Institute, Reuters reported. For that reason, the health body recommended that the vaccine only be given to people ages 18 to 64, according to Reuters and the Financial Times.

    COVID-19 vaccines from Moderna and Pfizer have already already been approved by the the EU regulator, the European Medicines Agency (EMA), and can be given to older adults.

    AstraZeneca's vaccine has been authorized for emergency use in seven countries — the UK, India, Argentina, Dominican Republic, El Salvador, Mexico and Morocco — for the immunization "of adults". Eighty-two year-old Brian Pinker was the first to receive the AstraZeneca shot outside of a trial on January 4.

    It isn't yet authorized for use in Germany or other EU countries. The EMA is expected to make a decision on whether to approve the vaccine on Friday.

    It follows an announcement Tuesday from the German health ministry that reports in German media that AstraZeneca's COVID-19 vaccine was less effective in older people were unfounded.

    However, even though the reports appear misguided, the EMA might not make the same decision as other regulators, and it has had more data from older people to look at.

    "It has been known since the autumn that in the first studies that AstraZeneca submitted, fewer older people took part than in the studies of other producers," the ministry said Tuesday, per the Financial Times.

    Jens Spahn, Germany's Health Minister reportedly said Thursday, however, that the recommendation from the vaccination commission is not final, and that the judgment depends on the EMA decision.

    "I don't think it's a good idea to speculate now on the basis of temporary results from the commission's consultations," Spahn told Politico.

    Oxford University, who co-developed the vaccine, said in a statement Tuesday that results of the clinical trials had been published transparently in five peer-reviewed scientific publications, and showed similar immune responses in younger and older adults and a good safety profile, and high efficacy in younger adults.

    In a paper publish in the journal Lancet in December 2020, Oxford researchers said there isn't yet enough data to tell whether the vaccine works in older people. They said they're still collecting more data for a future analysis.

    The researchers also said that earlier data on how the vaccine affects the immune systems of older people suggests that it should work in older adults.

    This is the latest tussle over AstraZeneca's vaccine by EU countries. There are already tensions between AstraZeneca and the EU due to potential vaccine shortages.

    /* src.: https://www.businessinsider.com/germ...21-1?r=DE&IR=T
    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

  6. #166
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475




    Nan y: B.1.351




    South Africa suspends rollout of Oxford-AstraZeneca coronavirus vaccine

    One study, involving around 2,000 people, found the vaccine offered "minimal protection" against mild and moderate cases of Covid-19. The government says it will use other vaccines in the meantime.


    The B.1.351 variant is responsible for 90% of infections in South Africa

    South Africa on Sunday said it would suspend its rollout of the Oxford-AstraZeneca vaccine after initial trials showed "disappointing" results against the B.1.351 variant of COVID-19 .

    The country has received 1 million doses of the jab. It had planned to start using it to vaccinate frontline healthcare workers from mid-February.

    The study, involving around 2,000 people, found the vaccine offered "minimal protection" against mild and moderate cases of COVID-19. It has not yet been peer-reviewed.


    Zweli Mkhize, South Africa's health minister, says that frontline health workers will receive jabs produced by other manufacturers instead.

    "We have decided to put a temporary hold on the rollout of the (AstraZeneca) vaccine. More work needs to be done," said South African Health Minister Zweli Mkhize.

    Scientists will be studying whether or not the AstraZeneca vaccine is effective in preventing severe disease and death against the new variant, Mkhize said.

    South Africa still eyes vaccination drive

    The government will instead offer vaccines produced by Johnson & Johnson and Pfizer in the coming weeks.

    This newer strain is more infectious and currently accounts for more than 90% of the COVID-19 cases in the country.

    South Africa plans to vaccinate at least 67% of its population by the end of the year, or around 40 million people.

    It has recorded nearly 1.5 million infections and more than 46,000 deaths from the virus.

    Developers vow modified jab by autumn

    Developers of theOxford-AstraZeneca vaccinesay they will have a modified jab ready by the end of this summer.

    Sarah Gilbert, lead researcher for the Oxford team, told the BBC on Sunday that "we have a version with the South African spike sequence in the works."

    "It looks very likely that we can have a new version ready to use in the autumn," she added.

    The early results for the AstraZeneca vaccine against the South African variant could have far-reaching implications in the fight against coronavirus on the continent.

    Many African nationshad been planning to use the AstraZeneca shot owing to its affordability and the fact that it can be kept in ordinary refrigerators

    COVAX, an international procurement initiative for poorer countries, has bought the AstraZeneca vaccine in bulk from the Serum Institute of India.

    jf/aw (AFP, AP)

    /* src.: https://www.dw.com/en/south-africa-s...ine/a-56491411



    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

  7. #167
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475


    Đừng nghe lời tà-ma tọc-mạch. Nhất là từ miệng
    những người tự phong là "chuyên gia". Chuyên
    gia bàn phím nói dóc thì có dư.




    Fact check: Are COVID-19 vaccines causing deaths?

    Online claims of coronavirus vaccines being lethal are rife following a string of deaths in care homes that vaccinated residents. DW looks into cases around the world and what was behind them.


    Rumors of alleged vaccine-related deaths have helped to fuel anti-vaccine and conspiracy theory supporters

    With coronavirus vaccine distribution well underway around the world, all eyes are on those who have already received the jabs.

    For those who don't read past the headlines, a concerning narrative appears — "Fifteen deaths after coronavirus vaccination," "Deaths at care home after coronavirus vaccine," "Volunteer in vaccine trial dies after COVID-19 vaccine."

    In each case, there's more to the story than meets the eye. DW reviewed several cases in Germany, Spain, the United States, Norway, Belgium, and Peru, finding that in all cases experts from multiple health authorities could not find causal links between the vaccination and deaths.

    As of publication, at least 37 million coronavirus vaccinations have been administered in these countries, according to Bloomberg's global vaccine tracker. In those countries, the total number of reported deaths that have occurred post-vaccination is fewer than 250. As US data includes user-submitted information, at least 181 of these cases have not been independently verified.

    Germany: 'Deaths after coronavirus vaccination'

    The Paul Ehrlich Institute (PEI), which is in charge of vaccination in Germany, investigated 10 deaths in the country between several hours to four days following coronavirus vaccinations. In all these cases, those who died were aged from 79 to 93 years old and had pre-existing conditions, according to Brigitte Keller-Stanislawski, the head of the PEI's department of safety for medical products.

    "Based on the data that we have, we assume that the patients died of their underlying disease — in a coincidental time with the vaccination," she told German broadcaster n-tv. While she did not comment on individual cases, she said, "They were very seriously ill patients with many underlying diseases."

    "If the elderly or people with severe pre-existing conditions are vaccinated, there will be a certain number of accidental deaths that occur shortly after vaccination, which cannot be causally associated with the vaccination. In its latest safety report, the Paul Ehrlich Institute highlights the cases of 20 vaccinated individuals who died in the setting of the COVID-19 disease.

    A press spokeswoman told DW via email that "all of them except one man had incomplete vaccination protection, since the COVID-19 disease occurred after the first vaccination. Protection begins seven to 14 days after the second vaccination (depending on the vaccine) so it is possible to become ill and die from COVID-19 after receiving only the first dose. 33 Individuals with multiple pre-existing conditions are either suffering from the worsening of their underlying disease or from another disease independent of vaccination. Ten individuals died from another infectious disease, not COVID-19."

    "In all other persons, there were in some cases multiple previous diseases such as carcinomas, renal insufficiency, heart diseases and arteriosclerotic changes, which were presumably the cause of death," she added.

    According to calculations of the Paul-Ehrlich-Institut in this report, the deaths with an unclear cause reported by 31.01.2021 are not more frequent than the expected number of deaths.

    In Germany, the BioNTech-Pfizer and Moderna coronavirus vaccines are being used.

    Spain: 'At least seven die at care home after getting Pfizer COVID-19 jab'

    Spanish media report that nine people died in a Spanish care home after receiving the first dose of the BioNTech-Pfizer vaccination, all of whom had previous illnesses.


    The reported deaths in a Spanish care home have been attributed to complications arising from COVID-19 infections

    The director of the El Salvador residence for the elderly in Lagartera said symptoms "such as headaches or occasional diarrhea" started showing in residents after five days and a doctor told him these could be due to side effects of the vaccinations.

    All nine deaths have been attributed to complications with COVID-19 infection, as the consequence of an outbreak that took place while the vaccination schedule was underway.

    The manager of the care home said: "The vaccine will protect you, infections are not derived from the first vaccination."

    Even after a vaccination, it's possible to develop the illness if the vaccination took place during the coronavirus incubation period (5-6 days). It is also possible to become infected after the vaccination has been administered, as it usually takes effect 10-14 days after the first dose, according to the Robert Koch Institute for Infectious Diseases (RKI).

    BothRussian andChinese state media have heavily reported on this case, with the latter citing the former.

    Despite the attention-grabbing headline, the original article from Russian state media clearly states, "There is currently no indication that the vaccine played any role in the deaths."

    It then refers readers to a fact-check stating that "It is statistically inevitable that some people will get sick and die after getting the shot, for reasons that are unrelated to their body's response to the vaccine." This disclaimer is missing from those who have replicated the article.

    US: 'Government database shows 181 deaths following COVID-19 vaccine'

    Widely reported in India, this claim is based on a press release by Children's Health Defense, an anti-vaccination advocacy group headed by prominent anti-vaxxer Robert F. Kennedy, Jr., and known for producing misinformation on vaccines and anti-vaccine propaganda.

    Although the headline claims that data comes from a "government database," the figures linked to are on the website of the National Vaccine Information Center, an organization described as "the most powerful anti-vaccine organization in America," by science, technology and public health journalist Michael Specter.

    Digging deeper, the National Vaccine Information Center (NVIC) claims their data is drawn from the US Government's Vaccine Adverse Event Reporting System (VAERS), which explicitly states "anyone can submit a report to VAERS, including parents and patients," and that "VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness."

    Furthermore, VAERS encourages vaccines providers to report significant health problems "whether or not they believe the vaccine was the cause," and disclaims that its data "cannot be interpreted or used to reach conclusions about the existence, severity, frequency, or rates of problems associated with vaccines" and "should be interpreted in the context of other scientific information."

    As far back as 2015, a study assessing claims of deaths from vaccinations highlights that data from the VAERS system is skewed, as it is a system which "accepts any submitted report of an adverse event without judging its clinical significance or whether it was caused by a vaccination." The Centers for Disease Control and Prevention also warns against reporting bias and inconsistent data quality in the VAERS system.

    However, the NVIC also solicits reports through its own website in the same basic format as the VAERS report. It does not specify whether the two datasets are combined in their database or kept separate.

    Norway: '30 people died in nursing homes following the coronavirus vaccine'


    The Norwegian Medicines Agency says there's no connection between deaths in a nursing home and the vaccine.

    The Norwegian Medicines Agency, Statens Legemiddelverk, has investigated a total of 33 reports of deaths in nursing homes following vaccination of residents, as of January 26, 2021.

    In a subsequent analysis, the agency writes "many of the nursing home residents who have been vaccinated so far are very frail or terminally ill patients. Every day, an average of 45 people die in Norwegian nursing homes or other similar institutions. Therefore, deaths that occur close to time of vaccination is expected, but it does not imply a causal relationship to the vaccine."

    The European Medicines Agency'sPharmacovigilance Risk Assessment Committee (PRAC) also investigated the cases, stating in a report that "the review did not reveal any safety concerns," adding, "(multiple) pre-existing diseases seemed to be a plausible explanation for death. In some individuals, palliative care had already been initiated before vaccination."

    When assessing the cases, an article in the British Medical Association's peer-reviewed medical trade journal quotes Steinar Madsen, medical director of the Norwegian Medicines Agency saying, "There is no certain connection between these deaths and the vaccine." Instead, Madsen said that "common adverse reactions, that are not dangerous in fitter, younger patients and are not unusual with vaccines, may aggravate underlying disease in the elderly."

    "We are not alarmed or worried about this, because these are very rare occurrences and they occurred in very frail patients with very serious disease," he said.

    Belgium: 'Fourteen deaths after coronavirus vaccination'

    In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) reported that 14 people died after being vaccinated against the coronavirus. However, causality has not been found.

    All of the patients were over 70 and five over 90, the Brussels Times reported. Further details of the individuals who died have not been released.

    "The fact that the reported deaths did not present a common clinical picture is a rather reassuring element, as is the fact that the deaths occurred after a variable period of time," the FAMHP told the Brussels Times, adding "to date, no causal relationship has been formally found" with the COVID-19 vaccine.

    As a result, the FAMHP has published weekly reports examining vaccine side effects. The February 4 report outlined "To date, no formal causal relationship with the COVID-19 vaccine has been established."

    Although the exact vaccinations were not specified in these cases, Belgium issues the Pfizer/BioNTech and Moderna coronavirus vaccines.

    Peru: 'Volunteer in vaccine trial dies of COVID-19 pneumonia'


    A volunteer (not pictured above) in a Peruvian trial of a Chinese vaccine died of pneumonia related to COVID-19, however she had been given a placebo, not the vaccine.

    Cayetano Heredia University, which was conducting a study on China's Sinopharm vaccination had to unblind a local Peruvian trial after a participant died of COVID-19-related pneumonia, according to Reuters.

    After unblinding the trial, it was revealed that the volunteer who died has not been administered the vaccine but was instead in the placebo group. In a statement, the university said, "It is important to stipulate that the death of the participant is not related to the vaccine since she received the placebo."

    /* src.: https://www.dw.com/en/fact-check-are...ths/a-56458746


    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

  8. #168
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475


    Oxford/AstraZeneca to begin vaccine trials on children as young as six



    Hundreds of children are being recruited to trial the Oxford/AstraZeneca coronavirus vaccine as it continues its roll-out to adults worldwide.

    The vaccine, ChAdOx1 nCoV-19, is currently only administered to those aged over 18 - but the new study aims to broaden this grouping further.

    Scientists are looking for 300 volunteers aged between six and 17 to participate in the year-long trial, where 240 will be given the COVID-19 vaccine, and 60 a control meningitis vaccine.

    Anyone aged between 16 and 17 is eligible to make the decision to take part themselves, while anyone younger would need the permission of a parent or guardian.

    This is not the first COVID vaccine to be tested on children; Pfizer began trials on those aged between 12 and 16 in October, while Moderna did the same in December.

    "It is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination," said chief Oxford trial researcher Andrew Pollard, who also noted children are least likely to experience severe effects of the disease.

    "For most children, for themselves, COVID is really not a big problem […] However, it is certainly possible that wider use to try and curb the progress of the pandemic might be considered in the future, so here we’re just trying to establish the data that would support that if indeed policymakers wanted to go in that direction."

    /* src.: https://www.euronews.com/2021/02/13/...s-young-as-six
    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

  9. #169
    Biệt Thự Triển's Avatar
    Join Date
    Sep 2011
    Posts
    23,475


    New COVID variant found in Finland may not show up in tests





    Experts have warned that a new mutated strain of the COVID- 19 virus that was discovered in Finland on Thursday may not show up in PCR tests, potentially fuelling the spread of the disease.

    Vita Laboratories stated that the Finnish variant, which is known as Fin-796H, is different from the strains found in the UK and South Africa, despite sharing some characteristics.

    The Helsinki-based laboratory said that the mutation is unlikely to have originated in Finland, given the country’s relatively low infection rates.

    Ilkka Julkunen, Professor of Virology at the University of Turku, told Yle that the emergence of the new strain is not yet a major concern, as it is still unclear whether it is more infectious than previous variants or resistant to vaccines.

    According to the Finnish Institute for Health and Welfare (THL), a total of 450 cases of new virus variants have been confirmed in Finland so far. Of these 427 were cases of the UK variant, 22 of the South African variant and one of the Brazilian variant.

    /* src.: https://www.helsinkitimes.fi/finland...-in-tests.html
    http://dtphorum.com/pr4/signaturepics/sigpic726_7.gif

 

 

Similar Threads

  1. Coronavirus COVID-19 - WATCH AT YOUR OWN RISKS
    By TLNVN in forum Thời Sự Trong Ngày
    Replies: 57
    Last Post: 05-04-2020, 11:38 AM
  2. Replies: 1
    Last Post: 02-29-2020, 08:04 PM
  3. Replies: 0
    Last Post: 10-23-2019, 03:20 AM
  4. Replies: 5
    Last Post: 12-18-2011, 12:10 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
All times are GMT -7. The time now is 05:47 PM.
Powered by vBulletin® Version 4.2.5
Copyright © 2021 vBulletin Solutions Inc. All rights reserved.
Forum Modifications By Marco Mamdouh